Qiagen (NYSE:QGEN) Releases FY 2025 Earnings Guidance

Qiagen (NYSE:QGEN) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 2.280- for the period, compared to the consensus estimate of 2.350. The company issued revenue guidance of $2.1 billion-, compared to the consensus revenue estimate of $2.1 billion. Qiagen also updated its Q1 2025 guidance to 0.500- EPS.

Analyst Upgrades and Downgrades

Several analysts have weighed in on QGEN shares. Morgan Stanley reissued an “equal weight” rating and issued a $46.67 target price (down previously from $48.61) on shares of Qiagen in a report on Monday, January 6th. Jefferies Financial Group restated a “buy” rating and set a $52.50 target price (up previously from $40.83) on shares of Qiagen in a research report on Tuesday, December 10th. Hsbc Global Res upgraded shares of Qiagen to a “hold” rating in a research report on Thursday, October 17th. Finally, HSBC downgraded Qiagen from a “buy” rating to a “hold” rating and set a $47.64 price objective for the company. in a research report on Thursday, October 17th. Four research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $50.07.

Qiagen Trading Up 0.9 %

Shares of NYSE QGEN traded up $0.40 during trading on Wednesday, hitting $43.76. 1,533,236 shares of the company traded hands, compared to its average volume of 1,163,455. The company has a quick ratio of 1.89, a current ratio of 2.17 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $9.71 billion, a P/E ratio of 109.09, a P/E/G ratio of 3.10 and a beta of 0.36. The company has a 50-day moving average price of $43.80 and a 200-day moving average price of $43.26. Qiagen has a 1 year low of $40.15 and a 1 year high of $49.30.

Qiagen (NYSE:QGEN) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.61 EPS for the quarter, topping analysts’ consensus estimates of $0.60 by $0.01. Qiagen had a return on equity of 13.43% and a net margin of 4.73%. On average, equities analysts predict that Qiagen will post 2.23 EPS for the current year.

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.